| Filed On | Filing |
|---|---|
| 05 Mar 2019 |
Form 3/A: McMillan Wayde D., EVP, CFO
Holds 3,529 shares of Common Stock |
| 05 Mar 2014 |
Form 3/A: Wielinski Tracey Haas, VP, Global Regulatory, CA, QA
Holds 18,275 shares of Common Stock |
| 15 Feb 2008 | Form 3/A: Campbell Robert, Vice President for Clinical |
| 07 Feb 2008 |
Form 3/A: Nye Gordon E, Director
Holds 0 shares of No securities are beneficially owned |
| 05 Dec 2007 | Form 3/A: Boess Carsten, Chief Financial Officer |
| 15 May 2007 | Form 3/A: Silverstein Jonathan, Director |
Loading...
